This website is intended for healthcare professionals only

Case sharing by Prof. Thomas O. Carpenter : XLH – Management challenges during childhood & adolescence

Part 4 - Case Study of 9-year-old patient

More Videos

ANZBMS 2023 Case Study – XLH – Management considerations in adulthood (Prof Rory Clifton-Bligh)

ANZBMS 2023 Case Study – XLH – Burosumab initiation in adulthood (A.Prof Christian Girgis)

Website developed and funded by Kyowa Kirin Asia Pacific Pte. Ltd. © 2024 Kyowa Kirin Asia Pacific Pte. Ltd. SG-CRV-22-00006 AUG2024

logo-crysvita

This website is for healthcare professionals only, please login below or

Welcome to Crysvita.Asia website!

Crysvita.Asia website is a branded website to deepen the understanding of healthcare professionals on the treatment and management of X-Linked Hypophosphatemia (XLH) and Crysvita® (Burosumab).

It showcases results from clinical trials and treatment management, as well as useful information, resources, links and contact information.

Login below or create an account to get all the latest updates on XLH and Crysvita (Burosumab) from this website:

logo_header_01
logo-crysvita
logo-crysvita.png
logo-crysvita.png
logo-crysvita.png
logo-crysvita.png
logo-crysvita-1.png
You will be accessing an external site. Click “OK” to continue.